Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Treasury Shares: 2023-2024

Historic Treasury Shares for Whitehawk Therapeutics (WHWK) over the last 2 years, with Dec 2024 value amounting to $256,490.

  • Whitehawk Therapeutics' Treasury Shares rose 655.30% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 655.30%. This contributed to the annual value of $256,490 for FY2024, which is 687.79% up from last year.
  • Whitehawk Therapeutics' Treasury Shares amounted to $256,490 in FY2024, which was up 687.79% from $32,558 recorded in FY2023.
  • In the past 5 years, Whitehawk Therapeutics' Treasury Shares ranged from a high of $256,490 in FY2024 and a low of $32,558 during FY2023.
  • In the last 2 years, Whitehawk Therapeutics' Treasury Shares had a median value of $144,524 in 2023 and averaged $144,524.
  • Data for Whitehawk Therapeutics' Treasury Shares shows a peak YoY soared of 687.79% (in 2024) over the last 5 years.
  • Over the past 2 years, Whitehawk Therapeutics' Treasury Shares (Yearly) stood at $32,558 in 2023, then skyrocketed by 687.79% to $256,490 in 2024.